Tharimmune (THAR) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free THAR Stock Alerts $0.36 -0.01 (-2.70%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Tharimmune Short Interest DataCurrent Short Volume119,000 sharesPrevious Short Volume103,400 sharesChange Vs. Previous Month+15.09%Dollar Volume Sold Short$43,208.90Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares11,790,000 sharesFloat Size11,530,000 sharesShort Percent of Float1.03%Today's Trading Volume81,693 sharesAverage Trading Volume162,863 sharesToday's Volume Vs. Average50% Short Selling Tharimmune ? Sign up to receive the latest short interest report for Tharimmune and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTHAR Short Interest Over TimeTHAR Days to Cover Over TimeTHAR Percentage of Float Shorted Over Time Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. Tharimmune Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024119,000 shares $43,208.90 +15.1%1.0%0.3 $0.36 4/15/2024103,400 shares $37,337.74 +37.3%0.9%0.2 $0.36 3/31/202475,300 shares $32,394.06 +230.3%0.7%0.1 $0.43 3/15/202422,800 shares $8,094.00 -69.9%0.2%0 $0.36 2/29/202475,700 shares $29,121.79 +44.2%0.7%0.1 $0.38 2/15/202452,500 shares $20,412.00 -75.7%0.5%0 $0.39 1/31/2024216,000 shares $95,040.00 No Change1.3%0.2 $0.44 THAR Short Interest - Frequently Asked Questions What is Tharimmune's current short interest? Short interest is the volume of Tharimmune shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 119,000 shares of THAR short. 1.03% of Tharimmune's shares are currently sold short. Learn More on Tharimmune's current short interest. What is a good short interest percentage for Tharimmune? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.03% of Tharimmune's floating shares are currently sold short. Is Tharimmune's short interest increasing or decreasing? Tharimmune saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 119,000 shares, an increase of 15.1% from the previous total of 103,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tharimmune's float size? Tharimmune currently has issued a total of 11,790,000 shares. Some of Tharimmune's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tharimmune currently has a public float of 11,530,000 shares. How does Tharimmune's short interest compare to its competitors? 1.03% of Tharimmune's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tharimmune: Seelos Therapeutics, Inc. (6.86%), NexImmune, Inc. (0.55%), Kazia Therapeutics Limited (0.53%), Genprex, Inc. (2.46%), Bright Minds Biosciences Inc. (2.57%), Lipella Pharmaceuticals Inc. (1.05%), Clever Leaves Holdings Inc. (2.03%), Synaptogenix, Inc. (2.88%), GT Biopharma, Inc. (0.48%), Petros Pharmaceuticals, Inc. (3.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Tharimmune stock? Short selling THAR is an investing strategy that aims to generate trading profit from Tharimmune as its price is falling. THAR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tharimmune? A short squeeze for Tharimmune occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of THAR, which in turn drives the price of the stock up even further. How often is Tharimmune's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including THAR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Seelos Therapeutics Short Squeeze NexImmune Short Squeeze Kazia Therapeutics Short Squeeze Genprex Short Squeeze Bright Minds Biosciences Short Squeeze Lipella Pharmaceuticals Short Squeeze Clever Leaves Short Squeeze Synaptogenix Short Squeeze GT Biopharma Short Squeeze Petros Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:THAR) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits